Original Research ArticleInternational Journal of Research in Dermatology
Publication: Comparative in vitro evaluation of anti-inflammatory properties of selenium disulfide and ketoconazole-based topical formulations
Int J Res Dermatol. 2026;12(2):125-130.DOI10.18203/issn.2455-4529.IntJResDermatol20260370
Abstract
Background Seborrheic dermatitis and dandruff are chronic inflammatory scalp disorders associated with cytokine- mediated immune responses and impaired barrier function.
Methods This in vitro study compared the anti- inflammatory efficacy of two topical formulations—Selsun S (1% selenium disulfide + 3% salicylic acid) and a comparator (2% ketoconazole + 2% salicylic acid)—using THP-1 monocytic cells. Both formulations significantly suppressed TNF-α production (IC₅₀ <0.03 mg/ml), with the comparator (2% ketoconazole + 2% salicylic acid) exhibiting higher cytotoxicity.
Results Selsun S demonstrated greater potency in reducing IL-6 (IC50: 0.033 mg/ml versus 0.041 mg/ml) and IL-8 (IC50: 0.032 mg/ml versus 0.045 mg/ml), likely due to enhanced skin penetration from its higher salicylic acid content.
Conclusions These findings support Selsun S’s superior anti-inflammatory activity and tolerability, indicating its potential utility in managing inflammatory scalp conditions.
Keywords
Affiliations
- KET’s Scientific Research Centre, Animal Biotechnology and Biochemistry Division, Mumbai, Maharashtra, India
- Abbott Healthcare Pvt Ltd, Medical Affairs Division, Mumbai, Maharashtra, India
